JAK2 and myeloproliferative neoplasm: We found that the application of 0.5 to 1 μM MERCK60 sufficed to significantly reduce colony formation in cells from six different JAK2-mutated MPN patients in vitro compared with that in HSPCs from healthy donor controls (Fig. 2g).